Solventum Corporation SOLV
89.50
0.91
1.03%
as of 25 Sep
- Market cap
- $15.1B
- P/E
- 10.9×
Follow SOLV
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Solventum Corporation (SOLV) Free cash flow
Solventum Corporation's free cash flow for fiscal 2025 was −$10.0M, compared with $805.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$118.0M. Solventum Corporation ranks 54th of 55 Medical Instruments & Supplies companies by free cash flow.
Free cash flow, annual
Annual
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | −$10.0M | — |
| FY2024 | $805.0M | (50.46%) |
| FY2023 | $1.6B | 13.80% |
| FY2022 | $1.4B | — |
Quarterly
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $144.0M | — |
| Mar 2026 | −$273.0M | — |
| Dec 2025 | $32.0M | — |
| Sep 2025 | −$21.0M | — |
| 11 more quarters | Free account |
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| ALC Alcon compare | $1.6B |
| BAX Baxter International Inc. compare | $815.0M |
| COO The Cooper Companies, Inc. compare | $678.0M |
| ALGN Align Technology, Inc. compare | $675.6M |
| AVTR Avantor, Inc. compare | $454.7M |
| WST West Pharmaceutical Services, Inc. compare | $436.9M |
| ATR AptarGroup, Inc. compare | $314.6M |
| RGEN Repligen Corporation compare | $110.3M |
| SOLV Solventum Corporation | −$118.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on SOLV
- Revenue
- Net income
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement